Clinical trial
Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy
NCT00428935 · Nationwide Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00428935 |
|---|---|
| Title | Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy |
| Official title | Phase 1 Clinical Trial of rAAV2.5-CMV-mini-Dystrophin Gene Vector in Duchenne Muscular Dystrophy |
| Lead sponsor | Nationwide Children's Hospital, Other |
| Collaborators | AskBio Inc Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Duchenne Muscular Dystrophy |
| Intervention type | Biological |
| Interventions | rAAV2.5-CMV-minidystrophin (d3990) |
| Enrollment | 6 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Jan 30, 2007 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: